Funder
Government of Canada
Alberta-Innnovates Health Solutions
University of Calgary
Alberta Sepsis Network
Pfizer
bioMerieux
National Collaborating Centre for Infectious Diseases (Canada)
Baxter International
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health
Reference39 articles.
1. Burke JP. Infection control - a problem for patient safety. N Engl J Med. 2003;348:651–6.
2. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36:1433–7.
3. Luepke KH, Suda KJ, Boucher H, Russo RL, Bonney MW, Hunt TD, et al. Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications. Pharmacotherapy. 2017;37:71–84.
4. Knobler S, Institute of Medicine (U.S.). Forum on Emerging Infections. The economics of resistance. In: The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment: workshop summary. Washington, DC: National Academies Press; 2003. p. 107–29.
5. Kaier K. Economic implications of the dynamic relationship between antibiotic use and hospital-acquired infections. Value Health. 2012;15:87–93.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献